Non-invasive PD-L1 quantification using [18F]DK222-PET imaging in cancer immunotherapy

Non-invasive PD-L1 quantification using [18F]DK222-PET imaging in cancer immunotherapy

Background Combination therapies that aim to improve the clinical efficacy to immune checkpoint inhibitors have led to the need for non-invasive and early pharmacodynamic biomarkers. Positron emission tomography (PET) is a promising non-invasive approach to monitoring target dynamics, and programmed...

Full description

Bibliographic Details
Main Authors: Patrick M Forde, Dhiraj Kumar, Steven P Rowe, Lilja B Solnes, Ajay Kumar Sharma, Akhilesh Mishra, Kuldeep Gupta, Gabriela Lofland, Martin G Pomper, Edward W Gabrielson, Sridhar Nimmagadda
Format: Article
Language:English
Published: BMJ Publishing Group 2023-10-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/11/10/e007535.full

Internet

https://jitc.bmj.com/content/11/10/e007535.full

Similar Items